Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,903 | -81,645 | -52,437 | -41,481 | -24,970 |
| Depreciation Amortization | 14,240 | 12,237 | 10,433 | 2,188 | 2,080 |
| Accounts receivable | 881 | -3,296 | -1,269 | 3,524 | N/A |
| Accounts payable and accrued liabilities | 1,238 | 93 | -112 | 118 | N/A |
| Other Working Capital | 1,165 | -4,897 | -108 | 3,212 | 870 |
| Other Operating Activity | -56,551 | 15,616 | 7,491 | 2,487 | 390 |
| Operating Cash Flow | $-88,930 | $-61,892 | $-36,002 | $-29,952 | $-21,630 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 90,172 | -86,785 | -112,179 | 23,464 | N/A |
| PPE Investments | -6,259 | -5,938 | -953 | -558 | -2,800 |
| Net Acquisitions | N/A | N/A | -781 | N/A | 0 |
| Other Investing Activity | -3,275 | 0 | 0 | 0 | 18,680 |
| Investing Cash Flow | $80,638 | $-92,723 | $-113,913 | $22,906 | $15,880 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,497 | 169,506 | N/A | N/A | N/A |
| Debt Repayment | -1,781 | -1,425 | -3,776 | -1,118 | N/A |
| Common Stock Issued | 1,253 | 1,753 | 171,752 | 131 | N/A |
| Common Stock Repurchased | -16,419 | -266 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 9,345 | 1,230 |
| Financing Cash Flow | $-12,450 | $169,568 | $167,976 | $8,358 | $1,230 |
| Beginning Cash Position | 38,688 | 23,735 | 5,674 | 4,362 | 8,870 |
| End Cash Position | 17,946 | 38,688 | 23,735 | 5,674 | 4,360 |
| Net Cash Flow | $-20,742 | $14,953 | $18,061 | $1,312 | $-4,510 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,930 | -61,892 | -36,002 | -29,952 | -21,630 |
| Capital Expenditure | -6,259 | -5,938 | -953 | -558 | N/A |
| Free Cash Flow | -95,189 | -67,830 | -36,955 | -30,510 | -21,630 |